These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27943508)

  • 1. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
    Orsi E; Grancini V; Menini S; Aghemo A; Pugliese G
    Liver Int; 2017 Jul; 37(7):950-962. PubMed ID: 27943508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus].
    Kim MG; Choi WC
    Korean J Hepatol; 2006 Dec; 12(4):524-9. PubMed ID: 17237630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Association with Liver Diseases: An Overview for Clinicians.
    Hamed AE; Elwan N; Naguib M; Elwakil R; Esmat G; El Kassas M; Abd-Elsalam S; Moussa S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(3):274-280. PubMed ID: 30444204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of hepatogenous diabetes in liver cirrhosis.
    Holstein A; Hinze S; Thiessen E; Plaschke A; Egberts EH
    J Gastroenterol Hepatol; 2002 Jun; 17(6):677-81. PubMed ID: 12100613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients.
    Grancini V; Trombetta M; Lunati ME; Boselli ML; Gatti S; Donato MF; Palmieri E; Resi V; Pugliese G; Bonadonna RC; Orsi E
    J Hepatol; 2019 May; 70(5):954-962. PubMed ID: 30677460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatogenous diabetes - diagnostics and treatment].
    Gundling F; Schumm-Draeger PM; Schepp W
    Z Gastroenterol; 2009 May; 47(5):436-45. PubMed ID: 19418413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and characteristics of diabetes in 300 pre-liver transplant patients.
    Marselli L; De Simone P; Morganti R; Coletti L; Carrai P; Catalano G; Tincani G; Ghinolfi D; Occhipinti M; Filipponi F; Marchetti P
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):441-2. PubMed ID: 27089979
    [No Abstract]   [Full Text] [Related]  

  • 8. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation.
    Perseghin G; Mazzaferro V; Sereni LP; Regalia E; Benedini S; Bazzigaluppi E; Pulvirenti A; Leão AA; Calori G; Romito R; Baratti D; Luzi L
    Hepatology; 2000 Mar; 31(3):694-703. PubMed ID: 10706560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?
    García-Compeán D; González-González JA; Lavalle-González FJ; González-Moreno EI; Villarreal-Pérez JZ; Maldonado-Garza HJ
    World J Gastroenterol; 2016 Mar; 22(10):2869-74. PubMed ID: 26973383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis].
    Petrides AS
    Z Gastroenterol; 1999 Jun; Suppl 1():15-21. PubMed ID: 10444811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatogenous diabetes. Current views of an ancient problem.
    García-Compean D; Jaquez-Quintana JO; Maldonado-Garza H
    Ann Hepatol; 2009; 8(1):13-20. PubMed ID: 19221528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplant HbA1c and Glucose Metabolism Parameters in Predicting Posttransplant Diabetes Mellitus and Their Course in the First 6 Months After Living-Donor Renal Transplant.
    Rao N; Rathi M; Sharma A; Ramachandran R; Kumar V; Kohli HS; Gupta KL; Sakhuja V
    Exp Clin Transplant; 2018 Aug; 16(4):446-454. PubMed ID: 29251576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycated hemoglobin and liver disease in diabetes mellitus.
    Schnedl WJ; Wallner SJ; Piswanger C; Krause R; Lipp RW
    Wien Med Wochenschr; 2005 Sep; 155(17-18):411-5. PubMed ID: 16392439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic disturbances in liver cirrhosis (part 2), hepatogenous diabetes: diagnostic aspects and treatment].
    Gundling F; Seidl H; Löffler N; Strassen I; Schepp W
    Dtsch Med Wochenschr; 2010 Jan; 135(1-2):22-4. PubMed ID: 20024879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus in patients with cirrhosis: clinical implications and management.
    Elkrief L; Rautou PE; Sarin S; Valla D; Paradis V; Moreau R
    Liver Int; 2016 Jul; 36(7):936-48. PubMed ID: 26972930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatogenous diabetes in cirrhosis: academic sport or a neglected disease?
    Gundling F; Schepp W; Schumm-Draeger PM
    Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):469-71. PubMed ID: 22976313
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
    Wareham NJ; Pfister R
    Nat Rev Cardiol; 2010 Jul; 7(7):367-8. PubMed ID: 20577298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatogenous Diabetes: An Underestimated Problem of Liver Cirrhosis.
    Kumar R
    Indian J Endocrinol Metab; 2018; 22(4):552-559. PubMed ID: 30148106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.
    Garcia-Compean D; Jaquez-Quintana JO; Gonzalez-Gonzalez JA; Maldonado-Garza H
    World J Gastroenterol; 2009 Jan; 15(3):280-8. PubMed ID: 19140227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations among body mass index, insulin resistance, and pancreatic β-cell function in Korean patients with new-onset type 2 diabetes.
    Chung JO; Cho DH; Chung DJ; Chung MY
    Korean J Intern Med; 2012 Mar; 27(1):66-71. PubMed ID: 22403502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.